Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
USG-QLB with Compound Lidocaine and Esketamine in Colorectal Surgery
NCT05964985Unknown
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of lidocaine and esketamine in postoperative pain (4 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Postoperative opioid consumption. Status: unknown.
02
Drugs
lidocaineesketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05964985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05964985.